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Abstract: 59 
 60 
Objectives: The aim of the Hybrid Video Registry (HVR) is to assess the acute 61 
safety and efficacy of the Hybrid Approach in comparison to other contemporary 62 
methods of CTO PCI.  Background: Recently, multiple techniques in 63 
Percutaneous Coronary Intervention (PCI) for coronary Chronic Total Occlusions 64 
(CTO) have been synthesized into a method referred to as the “Hybrid Approach”. 65 
Methods:  194 video taped timed live cases from CTO PCI training workshops 66 
were analyzed by independent data abstractors and compared to three 67 
contemporary CTO PCI registries stratified by case complexity on the basis of 68 
the J-CTO score. Results: Overall procedural success was 95% of all cases 69 
attempted with an excellent safety profile. In the most complex lesion subset, 70 
which made up 45% of all HVR cases, success was 92.8%, which was 71 
significantly higher than either the Royal Bromptom (78.9%), or Japanese-CTO 72 
(73.3%) registries, p = 0.04 Hybrid vs. Royal Brompton, p = 0.006 Hybrid vs. 73 
Japanese-CTO). The Hybrid Approach was also associated with shorter 74 
procedure times and lower contrast utilization.  Conclusions: In a real world 75 
angiographic registry of complex CTOs, the Hybrid Approach to CTO PCI is safe, 76 
and may be superior to other contemporary approaches to CTO intervention with 77 
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respect to procedural success and efficiency among a diverse group of operators 78 
and lesion complexity. 79 
 80 
 81 
Introduction: 82 
 83 
Percutaneous Coronary Intervention (PCI) for coronary Chronic Total Occlusions 84 
(CTO) is associated with improvements in quality of life, left ventricular function, 85 
and perhaps survival (1-3).  Despite this evidence, many patients are not offered 86 
CTO-PCI as a therapeutic strategy (4). We developed a systematic approach to 87 
CTO-PCI called the “Hybrid approach”, which has been described in detail 88 
elsewhere (5). To date, there is a paucity of data on the success rate and 89 
efficacy of the hybrid approach.  In the current study we abstracted angiographic 90 
data from video recorded CTO-PCIs performed by hybrid operators to create the 91 
Hybrid Video Registry (HVR). Here we present acute success rate and 92 
procedural efficiency of the Hybrid approach and compare these outcomes to 93 
other published series of CTO-PCI.   94 
 95 
Methods: 96 
 97 
The hybrid approach refers specifically to an algorithmic analysis of the CTO 98 
angiogram and subsequent initial as well as provisional strategies to most 99 
efficiently perform CTO PCI.  Specifically, lesion length less than 20 mm are 100 
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approached with a wires escalation strategy as these lesions have been shown 101 
to have a high success rate with this approach (4).  Lesions greater than 20 mm 102 
are treated with an intention to perform dissection and re entry given the lower 103 
likelihood of efficient wire escalation leading to CTO crossing.  If the proximal cap 104 
is clear and the distal landing zone just beyond the distal cap is an adequate 105 
target, an antegrade approach is initially selected.  If either an ambiguous 106 
proximal cap or a poor distal landing zone exists, a retrograde approach is 107 
initially selected provided adequate interventional collaterals exist.  Utilizing this 108 
Hybrid approach, 194 Video taped, timed live case demonstrations were 109 
compiled from 25 two to four day CTO PCI training workshops across the United 110 
States and the United Kingdom between January 2011 and June 2013.  28 111 
Hybrid operators performed the cases at 9 centers. 10 operators had > 10 years 112 
of PCI experience, 15 had 5-10 years and 3 operators had < 5 years of 113 
experience performing PCI.  No patients were excluded on the basis of 114 
angiographic characteristics.  The video footage including fluoroscopy, 115 
hemodynamics, and audio commentary were transferred to digital media and 116 
randomly distributed to 9 independent data abstractors not involved in the 117 
performance of the cases.  A database including 61 data elements was 118 
constructed and populated from review of the cases.  Success was defined as 119 
TIMI > 2 flow and < 30% residual stenosis, the same definition used in the 120 
European CTO (ERCTO) registry.  TIMI 3 flow, which is considered an optimal 121 
outcome, was analyzed and additionally reported.  Patients gave informed 122 
consent, and all recordings were de identified.  Data from the Royal Bromptom, 123 
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Japanese CTO, and ERCTO registries were abstracted from the published works 124 
(6-8). The J-CTO score, a previously described index of CTO lesion difficulty, 125 
was calculated for each case in the HVR8.  Case time was defined as the time 126 
from the first guidewire or device to be introduced into the target vessel to the 127 
final angiogram.  Techniques for CTO PCI included antegrade and retrograde 128 
wire escalation, and antegrade and retrograde dissection and re-entry.   Wire 129 
escalation is defined as the use of increasingly aggressive guidewires as needed 130 
to ultimately cross the CTO segment into the true lumen.  Dissection and re-entry 131 
makes use of the sub intimal space within CTO segment with ultimate re-entry 132 
into the true lumen (5).  Categorical variables were analyzed using Chi Square or 133 
the Fischer’s exact test where appropriate.  Scalar variables were analyzed using 134 
the student’s t test.  All p values were 2 tailed and a p value of < 0.05 was 135 
considered statistically significant.  Statistical analysis was performed using 136 
SPSS version 21. 137 
 138 
 139 
 140 
 141 
Results: 142 
Angiographic and procedural characteristics: 143 
194 CTO lesions were included in the analysis. Table 1 contains the baseline 144 
angiographic characteristics of the hybrid video population and the comparator 145 
registries.  The target vessel was the right coronary artery (RCA) in 62%, left 146 
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anterior descending (LAD) in 23%, and left circumflex (LCX) in 13% of cases of 147 
the HVR cases.  J-CTO score was higher in the HVR as compared to either the 148 
Japanese-CTO or Royal Brompton registries (2.33 + 1.11 vs. 1.71 + 0.068 vs. 149 
1.87 + 1.2 respectively p<0.001 for  HVR vs. both Japanese-CTO and Royal 150 
Brompton).  There was a higher frequency of prior CABG in the HVR as 151 
compared to the J-CTO registry.  The case complexity in the HVR was high with 152 
a J-CTO > 3 in 45%, which was similar to the Royal Brompton registry 37%, p 153 
0.08, and higher than the Japanese-CTO registry 27%, p < 0.001.  154 
 155 
Four initial techniques were used in the HVR including antegrade wire escalation 156 
(AWE) in 28%, antegrade dissection and re-entry (ADR) in 49%, retrograde wire 157 
escalation (RWE) 8%, and retrograde dissection and re-entry (RDR) in 15% of 158 
cases.  The initial strategy attempted was successful in 67% of cases, or 1/3 of 159 
cases required a switch to a different technique.  Final successful strategy was 160 
AWE in 25%, ADR in 45%, RWE  in 7%, and RDR in 13%.  26% of cases that 161 
were started with an intention to utilize the retrograde approach ultimately 162 
required an antegrade strategy, the majority of which was ADR.  163 
 164 
The overall procedural success rate was 95%.  Final TIMI 3 flow was present in 165 
95% of successful cases.  Overall 87% of successful cases had TIMI 3 flow in all 166 
left ventricular side branches > 2 mm in diameter.   167 
 168 
 169 
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 170 
 171 
Success rate stratified by JCTO score: 172 
In low or intermediate J-CTO score lesions (score 0-2) there was no difference in 173 
success rates between the registries.  Among cases with a high JCTO score (> 174 
3), the success rate was 92.8% in the HVR, which was significantly higher than 175 
either the Royal Bromptom (78.9%), or Japanese-CTO (73.3%) registries, p = 176 
0.04 Hybrid vs. Royal Brompton, p = 0.006 Hybrid vs. Japanese-CTO). (figure 1).   177 
 178 
Efficiency Analysis 179 
Mean procedure time in the HVR was 82 + 53 minutes and105 + 58 in the 180 
ERCTO registry (p <0.0001).  No comparison with the Royal Brompton or J-CTO 181 
registries was possible for this variable because procedure time was not reported.  182 
Contrast utilization was also lower in the Hybrid registry when compared to 183 
ERCTO, 238 + 105, vs. 313 + 184 mls (p-<0.0001).  The J-CTO registry and 184 
Royal Brompton registries reported contrast, however standard deviations were 185 
not given so statistical comparisons could not be performed.  The absolute 186 
values were higher than the hybrid registry, 293 and 350 mls respectively.   187 
Radiation metrics were not uniform and therefore could not be compared among 188 
the registries. 189 
 190 
Safety Analysis 191 
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 9 
Safety was similar in all three registries with low rates of major perforation 192 
requiring intervention (table 2). Of the 5 perforations in the HVR, 4 required 193 
pericardiocentesis, and 4 required a covered stent.   194 
 195 
 196 
Discussion: 197 
 198 
The main finding of ur study was that the Hybrid approach to CTO PCI 199 
implemented by a broad spectrum of Hybrid operators is associated with a high 200 
success rate independent of case complexity as assessed by the J-CTO score.  201 
This differs from other contemporary registries in which escalating J-CTO scores 202 
predicted lower success rates.  It is notable that with low J-CTO score lesions, 203 
expert operators can achieve a high success rate using any of the available 204 
techniques.  However, among those with a J-CTO score greater than 2, success 205 
rate in the other contemporary registries was lower, while among the Hybrid 206 
operators success rate continued to exceed 90%.    207 
 208 
The difference in success rates among high JCTO patients may relate to the 209 
higher use of sub intimal techniques.   Early prospective use of these techniques 210 
may represent the major difference between Hybrid and non-Hybrid strategies.  211 
Antegrade or retrograde dissection and re-entry was utilized in 64% of the cases 212 
in the HVR, whereas these techniques were used in <26% of the cases in the 213 
Japanese-CTO and <38% of cases in the Royal Brompton registries.   214 
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 215 
Sub intimal dissections with a blunt catheter, such as the Crossboss (Boston 216 
Scientific, Natick, Ma), or a knuckled guidewire may increase efficiency in 217 
complex lesions when compared to traditional techniques, which aim to stay 218 
within the intimal plaque.  While wire escalation techniques both antegrade and 219 
retrograde were employed in the HVR in 60% of cases with a J-CTO score < 1, 220 
the prospective utilization of subintimal dissection and re-entry was higher in 221 
more complex lesions, representing 68% of lesions with a J-CTO score > 2. In 222 
addition, as a provisional strategy for antegrade wire escalation failure, 223 
antegrade dissection and re entry with the Stingray device (Boston Scientific, 224 
Natick, Ma) has been demonstrated to be safe and effective (9). 225 
 226 
Additionally, the retrograde approach to CTO intervention is not possible in 227 
nearly 20% of cases preselected due to uncrossable collaterals either with the 228 
guidewire or support catheter.  In these cases, the antegrade success rates are 229 
only 60% in a recently reported registry from Japan (10).  This limitation of 230 
retrograde CTO-PCI can be overcome in many instances with antegrade 231 
dissection and re entry.  In the Hybrid registry, of the 35 cases that began with a 232 
primary retrograde approach, 26% had failure to cross the collateral or failure to 233 
cross the CTO retrograde.  In these cases, ADR was successful 78% of the time, 234 
which exceeds the success rate with traditional techniques cited above.  This 235 
highlights the utility of ADR as a bailout when collateral crossing is not possible in 236 
a procedure initially selected for a retrograde approach.  237 
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 238 
Limitations of our study include the lack of available patient level data from the 239 
comparator registries.  These data would have allowed for propensity matching 240 
to more robustly compare contemporary approaches to CTO PCI.  In that case, 241 
we might expect the Hybrid approach to compare even more favorably than our 242 
study suggests given the significantly higher J-CTO score in our patient cohort.  243 
Cases were performed in the context of courses focused on teaching antegrade 244 
dissection and re entry along with retrograde techniques so those approaches 245 
may be over represented in these data, but nonetheless success rates are quite 246 
high with a good safety profile.  Due to the design of the HVR, rates of ischemic 247 
complications post PCI could not be ascertained so complete safety information 248 
is lacking.  Finally, we did not collect follow up data and cannot assess long-term 249 
patency or safety of sub intimal stenting.  A report from the J-Proctor 250 
angiographic follow-up study suggests that MACE and TVR rates among IVUS 251 
adjudicated intimal vs. sub intimal stenting are similar (11).  252 
Conclusion: 253 
Using a real world angiographic registry of complex CTOs, the Hybrid Approach 254 
to CTO PCI may be superior to other contemporary approaches to CTO 255 
intervention with respect to procedural success and efficiency among a diverse 256 
group of operators and lesion complexity.  With increasing lesion complexity, the 257 
prospective use of both antegrade and retrograde dissection and re-entry is safe 258 
and associated with excellent success rates. 259 
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Figure Legend 320 
 321 
Figure 1: Final success in the Hybrid Video Registry in comparison to the Royal 322 
Brompton and Japanese CTO registries stratified by J-CTO score. 323 
 324 
Figure 2: Distribution of J-CTO score as a measure of lesion complexity among 325 
the three registries. 326 
 327 
 328 
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Table 1 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Hybrid Registry  
(N=194 lesions) 
J-CTO Registry  
(N=498 pts, 528 
lesions) 
Royal Brompton 
Registry 
 (N=195 pts, 269 
lesions) 
p 
Lesion Length 29.9 + 24.4 13.5 + 13.0 22 (IQR 15-32) *<0.001 
Length > 
20mm 
63% 21% 63.1% *<0.001 
Ŧ
0.44 
Calcified 61% 58% 50.8% *0.036 
Ŧ 
0.72 
Tortuosity 31% 45% 22.1%  
* 
0.002 
Ŧ
0.06 
Blunt Stump 61% 38% 47.2% *<0.001 
Ŧ
 0.009 
Prior Failure 16% 10% 37.9% *0.082 
Ŧ
 0.10 
Prior CABG 30% 10% 29.2%  
*
<0.001 
Ŧ 
0.60 
J-CTO Score 2.33+1.11 1.71+0.068 
 
1.87+1.2 * <0.001 
Ŧ
<0.001 
*Hybrid Registry vs. J-CTO Registry,  
Ŧ
 Hybrid Registry vs Royal Brompton Registry 
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Table 2 
  Hybrid Registry 
(N=194 pts) 
J-CTO Registry 
(N=498 pts) 
Royal Brompton Registry  
(N = 195 pts) 
p 
Death 0% 0.4% 0% NS 
Any Perforation 6% 10% 4.6% *0.191 
Ŧ
0.625 
Perforation requiring 
Intervention 
2% 0.2% 1% *0.0371 
Ŧ
0.654 
*Hybrid Registry vs J-CTO Registry, 
Ŧ
 Hybrid Registry vs Royal Brompton Registry 
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Figure 1: Final success in the Hybrid Video Registry in comparison to the Royal Brompton and Japanese CTO 
registries stratified by J-CTO score  
77x38mm (300 x 300 DPI)  
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Distribution of J-CTO score as a measure of lesion complexity among the three registries.  
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